RE:RE:RE:RE:RE:RE:RE:RE:RE:Feeling positive"Patatoes are cooked" my friends. In less than 10 days, we will know if it will be a billion dollars market cap company.
My guess is that they will hit the 27%-28% TG reduction which will confirm that Acasti have a superior TG reduction profile than Amarin.
In March, one or more secondary end points will be reached.
In the meantime, financial markets are allergic to uncertainty and Acasti is an easy target for shorts and hedge funds.
I think they are setting themself up for major short squeeze, they are waiting for the Amarin FDA approuval/expended label, they will announce the database lock up and shorty Ph3 positive results, this combined with the Amarin expended label will trigger an SP vertical lift.
Don't be fooled by haters, shorts and Amarin frantic crowd.
GLTA